Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

South Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms

South Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSouth Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms

South Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms.

View Premium plansBrowse free archive reports